Menu

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy

By Lavely W.C., Delbeke D., Greer J.P., Morgan D.S., Byrne D.W., Price R.R., Hallahan D.E. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study

By Ha C.S., Kong J.S., Tucker S.L., McLaughlin P., Wilder R.B., Hess M.A., Cabanillas F., Cox J.D. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients

By M'kacher R., Girinsky T., Koscielny S., Dossou J., Violot D., Beron-Gaillard N., Ribrag V., Bourhis J., Bernheim A., Parmentier C., Carde P. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy

By Woodward W.A., Strom E.A., McNeese M.D., Perkins G.H., Outlaw E.L., Hortobagyi G.N., Buzdar A.U., Buchholz T.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation

By Woodward W.A., Strom E.A., Tucker S.L., Katz A., McNeese M.D., Perkins G.H., Buzdar A.U., Hortobagyi G.N., Hunt K.K., Sahin A., Meric F., Sneige N., Buchholz T.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Cosmesis from the patient's and the doctor's view

By Hoeller U., Kuhlmey A., Bajrovic A., Grader K., Berger J., Tribius S., Fehlauer F., Alberti W. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer

By Lee H.K., D'Souza W.D., Yamal J.-M.J., Pollack A., Lee A.K., Palmer M.B., Kuban D.A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma

By Ellis R.J., Vertocnik A., Kim E., Zhou H., Young B., Sodee B., Fu P., Beddar S., Colussi V., Spirnak J.P., Dinchman K.H., Resnick M., Kinsella T.J. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Family history of prostate cancer and relapse after definitive external beam radiation therapy

By Ray M.E., Dunn R.L., Cooney K.A., Sandler H.M. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?

By Nguyen K.H., Horwitz E.M., Hanlon A.L., Uzzo R.G., Pollack A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite